Cell & gene therapies

© Getty Images

Bio International 2024

Cytiva: 'BIO is a very important convention for us'

By Isabel Cameron

Life sciences business Cytiva is set to launch its new platform, designed to accelerate the manufacturing process for autologous CAR-T cell therapies. Find out more about the company's priorities, market challenges, expansion plans and more.

© Getty Images

Positive pre-IND meeting with FDA for new ovarian cancer cell therapy

By Isabel Cameron

Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, has completed a pre-investigational new drug (pre-IND) meeting with the FDA for a phase 1/2 clinical trial of its cell therapy product, CTH-401 for the treatment...